Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma

Abstract: The incidence of renal cell carcinoma is increasing, with up to one-third of patients presenting with metastatic disease. Combination therapy is used to prolong […]

Clinical Use of Checkpoint Inhibition in Kidney Cancer

Based on a presentation by Hans J. Hammers, MD, PhD, at the ASCO Genitourinary Cancers Symposium A “plethora of agents” to inhibit programmed death 1 (PD-1) […]